(Q33272485)

25 July 2017

Tumor-specific antivascular effect of TZT-1027 (Soblidotin) elucidated by magnetic resonance imaging and confocal laser scanning microscopy (English)

1 reference

25 July 2017

Tsugitaka Natsume

1

1 reference

25 July 2017

Junichi Watanabe

2

1 reference

25 July 2017

Kenji Ogawa

3

1 reference

25 July 2017

Kazuhiko Yasumura

4

1 reference

25 July 2017

Motohiro Kobayashi

5

1 reference

25 July 2017

31 January 2007

1 reference

25 July 2017

1 reference

25 July 2017

98

1 reference

25 July 2017

598-604

1 reference

25 July 2017

4

1 reference

describes a project that uses

25 July 2017

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

cites work

Induction of apoptosis in human cancer cells by TZT-1027, an antimicrotubule agent.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Vinca alkaloids: anti-vascular effects in a murine tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Applications of magnetic resonance in model systems: tumor biology and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00418.X

10.1111/J.1349-7006.2007.00418.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference